EX-FILING FEES 9 tm249520d2_ex-filingfees.htm EXHIBIT 107

 

Exhibit 107

 

Calculation of Filing Fee Tables

 

FORM S-1

(Form Type)

 

Cyclacel Pharmaceuticals, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

 

    Security
Type		   Security
Class
Title		   Fee
Calculation
or Carry
Forward Rule		   Amount
Registered		     Proposed
Maximum
Offering
Price Per
Unit		     Maximum
Aggregate
Offering
Price(1)(2)		     Fee
Rate		     Amount of
Registration
Fee		     Carry
Forward
Form
Type		     Carry
Forward
File
Number		     Carry
Forward
Initial
effective
date		     Filing Fee
Previously
Paid In
Connection
with
Unsold
Securities
to be
Carried
Forward		  
Newly Registered Securities
Fees to Be Paid   Equity   Common stock, par value $0.001   457(o)                   $ 10,000,000     $ 0.0001476     $ 1,476.00                                  
Fees to Be Paid   Equity   Common Stock Warrants to purchase shares of common stock(3)   457(g)                     —       —     $ 0                                  
Fees to Be Paid   Equity   Common stock issuable upon exercise of the Common Stock Warrants   457(o)                   $ 20,000,000     $ 0.0001476     $ 2,952.00                                  
Fees to Be Paid   Equity   Pre-funded warrants to purchase shares of common stock(3)(4)   457(g)                     —       —     $ 0                                  
Fees to Be Paid   Equity   Common Stock issuable upon exercise of the pre-funded warrants(4)   457(g)                     —       —     $ 0                                  
Carry Forward Securities
Carry Forward Securities   —   —   —     —       —       —       —       —       —       —       —       —  
    Total Offering Amounts             $ 30,000,000             $ 4,428.00                                  
    Total Fees Previously Paid                               2,952.00                                  
    Total Fee Offsets                               —                                  
    Net Fee Due                             $ 1,476.00                                  

  

(1) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933.

 

(2) Pursuant to Rule 416, the securities being registered hereunder include such indeterminate number of additional securities as may be issued after the date hereof as a result of stock splits, stock dividends or similar transactions.

 

(3) In accordance with Rule 457(g) under the Securities Act, because the shares of the common stock underlying the warrants are registered hereby, no separate registration fee is required with respect to the warrants registered hereby.

 

(4) The proposed maximum aggregate offering price of the common stock will be reduced on a dollar-for-dollar basis based on the offering price of any pre-funded warrants sold in the offering, and the proposed maximum aggregate offering price of the pre-funded warrants to be sold in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any common stock sold in the offering. Accordingly, the proposed maximum aggregate offering price of the common stock and pre-funded warrants (including the common stock issuable upon exercise of the pre-funded warrants), if any, is $10,000,000.